Chemours Co Stock Revenue

CC Stock  USD 28.88  1.51  5.52%   
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
The current year's Current Deferred Revenue is expected to grow to about 57.6 M, whereas Total Revenue is forecasted to decline to about 5.1 B.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Chemours Revenue Analysis

Chemours' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
 2021 2022 2023 2024 (projected)
Gross Profit1.4B1.6B1.5B1.2B
Total Revenue6.3B6.8B6.1B5.1B

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Chemours Revenue

    
  6.79 B  
Most of Chemours' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Historical and Projected quarterly revenue of Chemours

Projected quarterly revenue analysis of Chemours provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Chemours match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Chemours' stock price.

Chemours Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as Revenue. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Chemours Current Deferred Revenue

Current Deferred Revenue

57.65 Million

At present, Chemours' Current Deferred Revenue is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Chemours Co reported 6.79 B of revenue. This is 13.55% lower than that of the Chemicals sector and 52.67% higher than that of the Materials industry. The revenue for all United States stocks is 27.99% higher than that of the company.

Chemours Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.
Chemours is currently under evaluation in revenue category among related companies.

Chemours Institutional Holders

Institutional Holdings refers to the ownership stake in Chemours that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemours' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemours' value.
Shares
Geode Capital Management, Llc2023-12-31
2.3 M
American Century Companies Inc2023-12-31
1.4 M
Vaughan Nelson Scarbrgh & Mccullough Lp2023-12-31
1.4 M
Goldman Sachs Group Inc2023-12-31
1.3 M
Norges Bank2023-12-31
1.2 M
Charles Schwab Investment Management Inc2023-12-31
1.1 M
Northern Trust Corp2023-12-31
1.1 M
Legal & General Group Plc2023-12-31
1.1 M
Morgan Stanley - Brokerage Accounts2023-12-31
M
Blackrock Inc2023-12-31
16.5 M
Fmr Inc2023-12-31
16.4 M

Chemours Fundamentals

About Chemours Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Current Deferred Revenue54.9 M57.6 M
Total Revenue6.1 B5.1 B
Cost Of Revenue4.7 B3.8 B
Ebit Per Revenue 0.15  0.13 

Chemours Investors Sentiment

The influence of Chemours' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chemours. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Chemours' public news can be used to forecast risks associated with an investment in Chemours. The trend in average sentiment can be used to explain how an investor holding Chemours can time the market purely based on public headlines and social activities around Chemours Co. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Chemours' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Chemours' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Chemours' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Chemours.

Chemours Implied Volatility

    
  110.19  
Chemours' implied volatility exposes the market's sentiment of Chemours Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chemours' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chemours stock will not fluctuate a lot when Chemours' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chemours in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chemours' short interest history, or implied volatility extrapolated from Chemours options trading.

Pair Trading with Chemours

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.

Moving against Chemours Stock

  0.66DNMR Danimer Scientific Earnings Call TodayPairCorr
  0.6ASH Ashland Global Holdings Financial Report 7th of May 2024 PairCorr
  0.55NTIC Northern Technologies Report 11th of April 2024 PairCorr
  0.51WTTR Select Energy Services Financial Report 7th of May 2024 PairCorr
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:
Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis.
Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.91)
Dividend Share
1
Earnings Share
(2.00)
Revenue Per Share
40.243
Quarterly Revenue Growth
(0.16)
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.